HS Code 30043110.0 โ Medicaments containing insulin (retail)
Chapter 30 (Pharmaceutical Products) ยท Heading 3004 (Medicaments put up in measured doses or for retail sale) ยท Last updated: April 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30043110.0 (Medicaments containing insulin (retail)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $565.4K across 52 shipments, this code covers 1 distinct pharmaceutical products exported by 5 Indian manufacturers to 10 countries. The leading product under this classification is Insulin at $565.4K, followed by .
The top importing markets include Thailand, Mexico, Ethiopia. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $10.9K. Leading exporters include M/S. NOVO NORDISK A/S and SANOFI-AVENTIS SINGAPORE PTE LTD. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30043110.0
1 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Insulin | $565.4K | 52 | $4.22 | 15 |
Import Destinations โ HS Code 30043110.0
10 countries import products classified under HS Code 30043110.0 from India
Indian pharmaceutical exports under HS Code 30043110.0 reach 10 countries worldwide. The largest importer is Thailand ($21.7M), followed by Mexico ($14.6M), Ethiopia ($5.0M), Pakistan ($4.5M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.